Vytrus Biotech, S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 4.52 million compared to EUR 4.47 million a year ago. Net income was EUR 0.544943 million compared to EUR 0.605257 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 EUR | 0.00% | -0.82% | +30.11% |
Apr. 03 | Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.11% | 17.51M | |
-31.77% | 204M | |
-28.96% | 59.13M |
- Stock Market
- Equities
- VYT Stock
- News Vytrus Biotech, S.A.
- Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023